Article Type: Research Article Article Citation: Sula M. V. Feleti, Renê L. Aleluia, Suiany
V. Gervásio, Jean Carlos V. Dutra, Jessica R. P. Oliveira, Rita de Cássia R.
Gonçalves, Claudia M. Jamal, Ricardo M. Kuster, Beatriz G. Brasileiro, and Maria
do Carmo P. Batitucci. (2020). PHYTOCHEMICAL SCREENING, ANTIOXIDANT,
ANTI-CYTOTOXIC AND ANTICANCER EFFECTS OF GALINSOGA PARVIFLORA AND VERNONIA
POLYANTHES (ASTERACEAE) EXTRACTS. International Journal of Research
-GRANTHAALAYAH, 8(10), 84-98. https://doi.org/10.29121/granthaalayah.v8.i10.2020.1782 Received Date: 25 September 2020 Accepted Date: 26 October 2020 Keywords: Phenolic Content; Mass Spectrometry; Antioxidant
Activity; MTT Assay ABSTRACT The study was designed to investigate the chemical composition and the biological effects of G. parviflora and V. polyanthes ethanolic extracts in vitro. Total content of phenols, flavonoids and tannins was quantified by spectrophotometry; chemical characterization was permed by mass spectrometry (ESI (-) FT-ICR MS and APCI (+) FT-ICR MS analysis). Antioxidant activities were determined by FRAP and Fe2+ chelating methods. Extracts cytotoxicity was evaluated in human lymphocytes, sarcoma-180 (S-180) and human gastric adenocarcinoma (AGS) cells, by MTT assay. V. polyanthes presented higher total content of tannins and G. parviflora presented higher amount of phenols and flavonoids. Chemical characterization showed the presence of flavonoids, phenolic acids and sesquiterpene lactones in V. polyanthes extract, and steroids, phenolic acids and fatty acids (Poly Unsaturated Fatty Acids - PUFA) in G. parviflora extract. V. polyanthes extract stood out in the Fe2+ chelation test. G. parviflora extract did not present outstanding antioxidant results in the tested protocols. Both species showed a tendency to promote cytotoxicity in human lymphocyte cells. Regarding the antiproliferative effect, both species were able to reduce S-180 cell viability and G. parviflora extract showed high antiproliferative potential in the assay with AGS cells. These findings reinforce the medicinal use of these plants, as well as suggest their potential use for the development of new drugs and for the treatment of cancers. 1. INTRODUCTIONPlants from Asteraceae family produce several secondary metabolites, such as phenolic derivatives, terpenoids, such as sesquiterpene lactones, alkaloids and essential oils [1], [2], [3], [4]. This family is relevant in biochemical, economic and pharmacological aspects [5], [6], [7] and Galinsoga parviflora Cav and Vernonia polyanthes Less are included in the plant group. G. parviflora Cav., popularly known as gallant soldier or picão branco, is an herbaceous native from South America, abundant in agricultural areas of temperate and subtropical regions of the world [8], [9]. This plant is considered a non-conventional food plant and its leaves are used in salads, spices and sauteed in countries of North and South America and South Africa [8], [10], [11], [12], [13]. Dried leaves and the juice of G. parviflora have been used to treat dermatological disorders and hemorrhages, as well as, are used for analgesia and as an anti-inflammatory. Due to its high vitamin C concentration, this herb is also used to treat colds, flu, cold sores and to prevent scurvy [8],[14], [15], [16]. Phenolic compounds constitute the main class of phytochemicals isolated from this species, however, flavonoids, aromatic esters, diterpenoids, caffeic acid, steroids and phenolic acid derivatives were also isolated in G. parviflora [8], [9], [11], [14], [17]. Vernonia polyanthes Less., popularly known as assa-peixe, is a plant native of Brazil, well distributed in several country regions, being found mainly in the Cerrado and Atlantic Forest [4], [18], [19], [20]. V. polyanthes is found in open land, pastures, poorly fertile soils and along rivers and roads. It is considered an invasive plant in agricultural activities, being characterized as a honey plant [18], [19], [21], [22]. V. polyanthes is used therapeutically as an infusion to treat infections of the respiratory tract, muscle pain, kidney treatments, wounds, sprains, bruises, dislocations, hemorrhoids and uterus infections [18], [20], [23]. In addition, there are in vitro and in vivo tests that demonstrate its diuretic, antihypertensive, anti-hemorrhagic, sedative, abortive, anthelmintic, antiulcerogenic, anti-rheumatic, healing, anti-inflammatory, antinociceptive, antibacterial, antifungal, leishmanicidal and anti-tumor actions [18], [21], [23], [24], [25], [26], [27], [28], [29]. In the search for new compounds with antioxidant action, numerous plants have been evaluated and studied for their capacity to neutralize free radicals [30], which can assist in preventive medicine, delaying the development of chronic diseases [31]. Plants have a variety of molecules capable of capturing free radicals, such as flavonoids, polyphenols, anthocyanins, carotenoids, vitamins and other endogenous metabolites that exhibit antioxidant action [32], [33]. Plant antioxidants can act by different mechanisms, which in general are related to the ability to compete for active sites and cellular receptors, or by modulating the expression of genes encoding proteins involved in intracellular defence mechanisms against oxidative processes in cell structures [34], [35]. Thus, this study aimed to characterize the crude ethanolic extracts of G. parviflora and V. polyanthes in terms of their chemical composition, by spectrometric analyses, and to evaluate their antioxidant, cytotoxic and antiproliferative effects in vitro, as well as to establish the possible relationships between the chemical composition and biological activities exhibited by the extracts. 2. MATERIALS AND METHODSPlant extracts Plant
material was collected in Muriaé - MG, identified and a specimen voucher of G. parviflora and V. polyanthes was deposited at the Herbarium of the Universidade
Federal de Viçosa, registration code vic
53548 and vic 53549,
respectively. Both plants were registered with the National System for the
Management of Genetic Heritage and Associated Traditional Knowledge (SisGen),
registration number A8105A. Crude extracts of the total aerial part of the
herbs were obtained by exhaustive maceration, with 100% ethanol at room
temperature (25 - 30 ° C), protected from light, later filtered and
concentrated in a vacuum rotary evaporator. Chemical Analysis of
Extracts Total Phytocompounds
Content Total
content of phenolic compounds was tested according to the Zhang et al.[36], by Folin – Ciocalteu method. The total
flavonoid and tannin content were assessed by the protocols of Zhishen et al. [37] and Pansera et al. [38], respectively. The readings were taken on an
ELISA microplate spectrophotometer, at the wavelengths recommended for each
protocol. All analyses were performed in triplicate and the standards used were
the recommended in the protocols. ESI (-) FT-ICR MS analysis The
ethanolic extracts were analysed by Mass Spectrometry with Fourier Transform
Ion Cycle (FT-ICR MS) to determine the chemical profile. The samples were
solubilized (1.0 mg.mL-1) in a methanol solution, which was infused
at a rate of 2.0 µL/min in the negative mode electrospray (ESI). The Solarix
model 9.4 T mass spectrometer, Bruker Daltonics, Bremen, Germany, was
programmed to operate in a range of m/z
150 – 1500. The conditions of the ESI source used in the analysis were:
nebulizer gas pressure of 1.0 bar, capillary voltage 3.8 kV and capillary
transfer temperature of 200 °C. The ion accumulation time was 0.010 s, and each
spectrum was acquired by accumulating 32 scans with a 4M time domain (mega-point). Mass spectra were processed
using Data Analysis software (Bruker Daltonics, Bremen, Germany). APCI (+) FT-ICR MS analysis For sample
analysis, 1.0 mg of the extracts of V.
polyanthes and G. parviflora were
individually solubilized in 1.0 mL of methanol (99.5%, Vetec® Química Fina
Ltda, Brazil). The samples were injected directly into the APCI (+) source at a
flow rate of 20 mL.min-1. The dynamic range of ion
acquisition in the ICR cell was m/z 200 - 1200. Other APCI
source parameters were: voltage in the capillary (cone): 2,100.0 V; end plate
offset = - 500 V; drying gas temperature and flow: 180 ºC and 4 L min-1;
nebulizer gas pressure and temperature: 320 ºC and 2.0 bar; skimmer = 25 V;
collision voltage = - 2 V and corona discharge: 3000 nA. In ion transmission,
the ion accumulation time in the hexapole (ion
accumulation time) and TOF were 0.020 s and a range of 0.850 - 0.900 ms,
respectively. Each spectrum was acquired from the accumulation of 32 scans with
a time domain of 4M (mega-point). Mass spectra were acquired and processed
using Data Analysis software (Bruker Daltonics, Bremen, Germany). Antioxidant Activity Evaluation
of the antioxidant activity of the crude extracts was performed by FRAP and Fe2+
chelating activity. FRAP (Ferric Reducing Antioxidant Power) is
also known as Iron Reducing Antioxidant Power test. Following the protocol of
Rufino et al. [39], with modifications, FRAP reagent
was obtained from the combination of 0.3 mM acetate buffer solution, 10 mM TPTZ
(2,4,6-Tri (2-pyridyl) 1,3,5-triazine) solution and aqueous chloride solution
ferric 20 mM. In 2.0 mL microtubes, it was added 30 µL of the samples, 90 µL of
distilled water and 900 µL of the FRAP reagent. Microtubes were vortexed and
incubated in an oven at 37 ºC for 30 minutes. Thus, 250 µL of this solution was
added to a 96-well microplate, being performed the same with the blank,
reaction control and standards gallic acid, ferrous sulfate and Trolox. The
reading was performed on a spectrophotometer for ELISA microplate at 595 nm.
The calculation of Antioxidant Activity (AA%) was performed using the equation
below, with values expressed in EC50 (μg.mL-1). Fe2+
ion chelating activity test was performed as established by Tang et al. [40], with modifications. In a 1.5 mL microtube, it
was added 1000 µL of the sample, 50 µL of FeCl2 and 200 µL of
ferrozine. The microtube was vortexed, allowed to react for 10 minutes, the
solution was placed in 96-well microplates and read on an Epoch ELISA
spectrophotometer at 595 nm. Ascorbic acid, gallic acid and EDTA were used as
standards. All tests were performed in triplicate and the calculations for
assessing chelating activity (CA%) were based on the equation below, with
values expressed in EC50 (µg.mL-1). In vitro
cytotoxicity Cancer
cells Anticancer in vitro experiments were performed with
sarcoma 180 (S-180) and human gastric adenocarcinoma cells (AGS; ATCC
CRL-1739). Sarcoma-180 cells were
acquired from the Banco de Células do Rio de Janeiro, Brazil, and the AGS cells
were supplied by the Laboratório de Triagem Biológica de Produtos Naturais from
UFES. S-180 cells were previous cultured with culture medium RPMI 1640 and AGS
cells with DMEM medium, both cell lines supplied with 10% fetal bovine serum. Cells
were seeded in 96-well microplate, S-180 at 2.105 cells.mL-1
and AGS at 6.104 cells.mL-1 in each well, and previous
maintained at 37 ºC and atmosphere of 5% CO2. After 24
hours, cells were treated with seven different concentrations of the extracts
for 48h, starting from the initial concentration of 200 µg.mL-1 for V. polyanthes and 400 µg.mL-1
for G. parviflora. Assay was
performed in triplicate and cell viability was assessed using the MTT reduction
method. All protocols were in accordance to the Ethics Committee of Humans and
Animals Use. Human lymphocytes To assess the cytotoxicity in healthy cells, it was used the protocol of
Marullo et al. [41], with modifications by Dutra et.
al.[42]. Peripheral blood was collected
from a healthy donor, aged between 18 and 30 years, with free and informed
consent. Possible donors with history of recent disease, exposure to radiation
or drug use and alcohol ingestion thirty days before blood donating were
excluded from donating. All protocols were approved by the Research Ethics
Committee of the Universidade Federal do Espírito Santo Santo. In order to
compare the effects of extracts in cancer and healthy cells, human lymphocytes
were cultured under the same growth conditions of S-180 and AGS cells. To evaluate the anti-cytotoxicity, human
lymphocytes were treated with extract concentrations at 5.00, 25.00 or 50.00
µg.mL-1 and cisplatin at 50.0 µg.mL-1. Following the
protocol of pre-treatment, human lymphocytes received extract concentrations
and after 24 hours from the incubation received cisplatin; simultaneous
treatment, in which the extract concentrations and cisplatin were placed at the
same time; and post-treatment, where the lymphocytes were initially treated
with cisplatin and, after 24 h, received extract concentrations. Untreated
cells were used as a negative control (NC) and cells treated with cisplatin
were used as a positive control (PC). To evaluate the perceptual of cytotoxic
damage reduction it was used the formula from Serpeloni et al., adpted for
Dutra et al. [42], [43]: Where “A”
is the cell group treated with cisplatin; “B” is the cell group treated with
plant extracts more cisplatin; and “C” is the negative control group of cells. MTT assay The method
is based on the reduction of MTT ((3- (4,5-dimethylthiazol-2yl) -2,5-diphenyl
tetrazoline bromide) in a violet-colored product (formazan) by the
mitochondrial enzyme succinate-dehydrogenase, a reaction that can only occur in
viable cells. Thus, after 24h or 48h of the last treatment, human lymphocytes,
S-180 and AGS cells were subjected to the cell viability test using the MTT
assay. Microplates
were centrifuged at 860 rcf for 10 minutes and the supernatant was discarded.
20 µL of MTT at 5 mg.mL-1 were added to each well and incubated for
3 hours at 37 ºC and an atmosphere of 5% CO2. After the period, the
plates were centrifuged at 860 rcf for 5 minutes, the supernatant was discarded
and 100 µL of DMSO was added. The reading was performed on an Epoch ELISA
spectrophotometer at 595 nm. The experiments were carried out in triplicate and
the evaluation of cell cytotoxicity was calculated by the equation below and
expressed as a percentage of viable cells (% VC) and IC50 (µg.mL-1): Statistical analysis Results
were presented as mean ± standard error of the mean (SE). After verifying the
normality of the data, the comparison of means was performed by one-way
analysis of variance (ANOVA), followed by Tukey's test (p<0.05). In order to establish relationships between total
phenols, flavonoids and tannins content, antioxidant activities,
anti-cytotoxicity and anticancer effects of the extracts of G. parviflora and V. polyanthes, principal component analysis (PCA) and Pearson
correlation were performed. For PCA analysis and Pearson correlation, the
results of S-180 anticancer effects at the concentration of 50.0 μg.mL-1 were used, since this
concentration corresponds to the best results for anticancer activity. 3. RESULTS AND DISCUSSIONSChemical analysis of V.
polyanthes and G. parviflora extracts In a
comparison, the evaluation of the total content indicates that G. parviflora
presents higher values of phenolic compounds and total flavonoids and that V.
polyanthes stands out for the total tannin content (Table 1). Table 1: Total Phenols, flavonoids and tannins in the
aerial parts extract of V. polyanthes and G. parviflora.
Values are
expressed as mean ± SE. SE: Standard error; GAE: Gallic Acid Equivalents; RE:
Rutin Equivalents; TAE: Tannic Acid Equivalents. Compounds
or classes of metabolites presented in extracts were proposed based on the ions
generated, number of unsaturations and rings (DBE) and data from the
literature. Fig. 1A and Table 2 show the chemical composition of the extract of
the species V. polyanthes by the negative ESI ionization source, and Fig. 2 A
and Table 3 indicate the results obtained from the APCI (+) FT-ICR MS. In
addition, Fig. 1B and Table 4 summarizes the chemical composition of G.
parviflora by the negative ESI ionization source, and Fig. 2B and Table 5
summarizes the results obtained by the positive APCI ionization source. Figure 1: Mass spectra obtained by
analyzing the ESI (-) source from top to bottom, of the species V. polyanthes
and G. parviflora. Mass spectra of V. polyanthe is represented by
(A); and G. parviflora is represented by (B). Figure 2: Mass spectra obtained by
analyzing the APCI (+) source from top to bottom, of the species V. polyanthes
and G. parviflora. Mass spectra of V. polyanthe is represented by
(A); and G. parviflora is represented by (B). Table 2: Compounds identified by ESI (-)
FT-ICR MS in the extract of V. polyanthes.
Table 3: Compounds identified by APCI
(+) FT-ICR MS in the extract of V. polyanthes
aNumber of unsaturations and rings (double bound equivalent) Table 4: Compounds identified by ESI (-)
FT-ICR MS in the extract of G. parviflora ethanolic.
aNumber of unsaturations and
rings (double bound equivalent). Table 5: Compounds identified by APCI
(+) FT-ICR MS in the extract of G. parviflora ethanolic
aNumber of unsaturations and rings (double bound equivalent). Chanaj-Kaczmareck et al. [9]
quantified phenolic compounds and total flavonoids in G. parviflora hydromethanolic extract and, compared to our study,
obtained low values of phenolic compounds (29.55 mg GAE.g-1) and
flavonoids (2.48 mg QE. g-1). It may occur due to the use of
different solvents or because the use of ethanol seems to favor the extraction
of the phenolic and flavonoid compounds of G.
parviflora. In addition, differences in climatic and edaphic variables and
possible differences in genotypes may have contributed to the variation in the
content of secondary metabolites [44], [45], [46]. In previous investigations, chemical analyzes of
ethanol extracts from V. polyanthes
leaves showed lower levels of flavonoids compared to our study [[23], [47]. In
contrast, in the study by Rodrigues [48] with
ethanolic extract of the leaves of V.
polyanthes, it was described levels of phenolic and flavonoids compounds
higher than those presented in our investigation. This finds reinforces the possible
influence of different study conditions on the total contents of phenolic and
flavonoid compounds. V. polyanthes is
rich in flavonoids, phenolic acids, chlorogenic acids and sesquiterpene
lactones [49], [50], [51]. Our results is corroborated by the study of
Martucci [21] and Martucci and Gobbo-Neto [52],
which indicate the presence of several compounds, such as dicaffeoylquinic acid,
monocafeoylquinic acid and luteolin-7-O-glucuronide
in V. polyanthes extract (Table 2).
Other studies also report substances similar to those identified in our study,
such as the dicaffeoylquinic acid and the flavonoid luteolin [48], [50], and phenolic
acids derived from cinnamic acid, such as ferulic acid and caffeine [53]. In the crude extract of V. polyanthes different compounds were identified by APCI (+)
FT-ICR MS, such as lactone 8β-2
methylacryloyloxy-isohirsutinolide, already described for this species (Table
3) [49], [54]. Similarly,
piptocarpine A, glaucolide A, 10α-acetoxy-8α-methylacryloyloxy-1 α-13-O-acetate
or 1β-methoxyhirsutinolide-
13-O-acetate have been identified in
previous studies [50], [51], [54]. Other studies indicate that G. parviflora exhibits a diversity of flavonoids derived from
caffeic acid, steroids, among others [8], [55], [56] which is in accordance to the study of Bazylko
et al. [57], with
ethanolic extract, that identified phenolic acids, such as caffeic,
caffeoylquinic and dicafeoylquinic acid, using HPTLC; and also in accordance to
the results of Dudek et al. [55], with
hydrophilic extract of aerial parts, that identified substances derived from
caffeic acid, such as 5-O-caffeoylquinic
acid (chlorogenic acid), 1, 3-O-
dicaffeoylquinic acid, 3, 5-O-dicafeoilquin,
using spectrometric techniques. Meanwhile, the findings presented in our study (Table
5) corroborate those reported by Mostafa et al. [56] and Anwar et al. [58] that
indicate the presence of stigmasterol, β-sitosterol and β-sitosterol in G.
parviflora extracts. In addition, caffeic acid derivatives found in G. parviflora has been identified as an
important protective factor for dermal fibroblasts against oxidative stress
induced by ultraviolet radiation (UVA), by activating the cellular antioxidant
system in a study by Parzonko and Kiss [59]. Polyunsaturated fatty acids (linolenic and linoleic
acid) and some monounsaturated (palmitoleic, palmitic and ricinoleic acid) were
also identified in G. parviflora
(Table 4), which has not yet been reported for this species. Public health
authorities consider nutraceuticals as powerful instruments in maintaining
health against nutritional problems and chronic diseases, with improvement in
the individual's quality of life [60]. Thus,
the presence of fatty acids in G.
parviflora indicates the promising uses of this herb as a nutraceutical. On this way, long chain polyunsaturated fatty acids
(linolenic and linoleic), PUFAs, compounds not synthesized by humans, must be ingested
through the diet (fish, seeds and vegetable oils). PUFA n-3 (linolenic acid)
and PUFA n-6 (linoleic acid) acts, respectively, in anti-inflammatory and
pro-inflammatory process, therefore, must to be in balance [61], [62], [63]. Despite the controversies, omega-3 fatty acid
supplementation has been recommended and studies have reported satisfactory
results regarding its regular dietary intake, with favorable effects on
triglyceride levels, coagulation and blood pressure, heart rate, cancer
prevention, reduction in the incidence of arteriosclerosis and in the prognosis
of symptomatic heart failure or myocardial infarction [64], [65], [66]. Antioxidant activity of V.
polyanthes and G. parviflora extracts Antioxidant activities of V. polyanthes and G.
parviflora extracts, by FRAP and Fe2+ chelating activity is
shown in Table 6. G. parviflora
demonstrates lower antioxidant activity, when compared to V. polyanthes, in both tests. Following statistical analysis, V. polyanthes extract presented
antioxidant activity comparable to the standards in the Fe2+
chelating test; while the same was not observed for G. parviflora extract in tested conditions. Table 6: Antioxidant activity of V.
polyanthes and G. parviflora ethanolic extracts by FRAP and Fe2+ chelating
methods.
Values are expressed as mean ± SE (n = 3); SE:
Standard error; values followed by different letters (a, b, c, d or e) differ
statistically; ANOVA, post hoc Tukey test (p<0.05). It was observed in the study of Studzinska-Sroka et
al. [16], with
hydroalcoholic extract of G. parviflora,
considerable antioxidant activity in the FRAP assay, with EC50 =
498.20 µg.mL-1. It was also verified in the G. parviflora extract, by liquid chromatography (UPLC-PDA), the
presence of phenolic acids, such as chlorogenic, caffeic and isovanyl acids,
and 4-hydroxybenzoic. In conclusion, the authors stated that the application of
G. parviflora extract of in cutaneous
lesions allowed the healing of wounds and exhibited antioxidant,
anti-inflammatory and hyaluronidase inhibitory activities. In addition, studies
indicate significant antioxidant activity of V. polyanthes extracts, such as in FRAP assay, different to the reported
in our study, and correlate antioxidant effects to the levels of total phenolics
and flavonoids, such as rutin and quercetin [23], [47], [58]. V. polyanthes extract stood out in the Fe2+
chelating test (Table 6), a condition similar to the observed in two fractions
of V. amygdalina (ethanolic
polyphenol and acetone eluate) that exhibited high chelating power [67]. Cytotoxicity of V.
polyanthes and G. parviflora extracts The cytotoxic activity of V. polyanthes and G.
parviflora in S-180 and AGS cells after 48 hour of treatment was presented
as IC50. The results with S-180 cells suggest that V. polyanthes extract presented IC50
lower than 5.00 µg.mL-1, while G.
parviflora presented IC50 = 5.26 ± 1.09 µg.mL-1. Following the results with AGS
cells, V. polyanthes extract
presented IC50 = 8.47 ± 0.55
µg.mL-1 and stands out in relation to G. parviflora, with IC50 = 60.97 ± 0.39 µg.mL-1, showing cytotoxic effect against
AGS cells. In the experiments with human lymphocytes, V. polyanthes extract presented IC50 = 46.42 ± 3.50 µg.mL-1 and G. parviflora presented IC50
= 48.48 ± 1.89 µg.mL-1. In a comparison, V.
polyanthes and G. parviflora extracts
showed similar anticancer activity against S-180 cells; however, the extract of
V. polyanthes was more cytotoxic for
AGS cells than the extract of G.
parviflora. In addition, the cytotoxicity induced by extracts in human
lymphocytes did not differ. Following the protocols of the anti-cytotoxicity, the
results showed that in the pre and simultaneous treatment, both species were
not able to avoid the cytotoxic damage induced by cisplatin. In the
post-treatment, it was observed, for the highest tested concentrations of V. polyanthes extract, a tendency to
reverse cisplatin induced damage. For G.
parviflora extract, only the concentration of 25µg.mL-1 showed a
promising action against cisplatin damage (Table 7). Table 7: Percentage of viable human lymphocytes
treated with different concentrations of the V. polyanthes and G. parviflora
extracts at different concentrations, following the pre, simultaneous and
post-treatment protocols.
Cisplatin is a highly reactive molecule used in the
treatment of cancer due to the ability to bind to proteins and phospholipid
membranes. In addition, cisplatin can interact with RNA and DNA, forming
adducts that may inhibits the replication, transcription or interrupt the cell
cycle and activation of apoptosis, generating genotoxic and cytotoxic effects [68], [69]. Our results
suggest that V. polyanthes and G. parviflora act on human lymphocytes
repair mechanism, positively interfering with the maintenance of cellular
homeostasis, even after interaction with cisplatin. To our knowledge, there are no studies involving
simultaneously V. polyanthes extract,
human lymphocytes, S-180 and AGS cells. However, studies with other species of
the genus Vernonia have demonstrated
the promising uses of this group of herbs in trials with several cancer cell
lines. An example is the investigation of Amuthan et al.[70],
comparing the cytoprotective activity of V.
cinerea crude aqueous extract and its fractions in normal HEK293 kidney
cells and HELA cell lines, against cisplatin-induced cytotoxicity. Also
investigating anticancer activity, Siew al. [71],
showed that the methanolic extract of V.
amygdalina leaves showed antiproliferative activity against several cancer
cell lines. Traditionally, V. amygdalina
leaves are already used in popular Indian culture for the treatment of cancer,
and based on the excellent results that this species, the authors claim that
further studies are needed to understand its potential in the treatment of
cancer. Explorative
analyses: correlations between phytochemicals, antioxidant activity and
anticancer effects Results obtained in different assays were correlated
by PCA and Pearson correlation coefficient. The first principal component (F1)
accounted 76.05% and second principal component (F2) accounted 15.67%, with a
total variance of 91.72% (Fig. 3). Total phenol, flavonoid and tannins content,
FRAP, Fe2+ chelating, anticancer activity against AGS cells and
pre-treatment assay were the variables that dominated PC1. S-180 anticancer,
simultaneous and post-treatment assays were the variables that dominated PC2.
These finds suggest that anticancer activity against AGS cells was correlated
with total phenol and flavonoid content and FRAP and Fe2+ chelating
antioxidant activity, while anti-cytotoxic activity in the pre-treatment
protocol was correlated to the total tannins content. Following PCA analysis,
it was not possible establish correlations among chemical content of extracts
and human lymphocytes cytotoxicity, simultaneous and post-treatment assays. In
summary, V. polyanthes seems to be
correlated with cytotoxicity in AGS cells and anti-cytotoxicity in the
post-treatment protocol, while G.
parviflora seems to be correlated with cytotoxicity in sarcoma 180 cells,
and pre and simultaneous treatment. Figure 3: PCA (scores and loading plots,
biplot) based on total phenols, flavonoids and tannins content analysed in V.
polyanthes and G. parviflora extracts and their antioxidant activities in FRAP
and Fe2+ chelating activity and cytotoxic, anti-cytotoxic and anticancer
effects by MTT assay. Cell viability was evaluated by MTT assay using human lymphocytes
(HL MTT), S-180 (S-180 MTT) and AGS cells (AGS MTT); or after perform the
protocols of pre (Pre-treat.), simultaneous (Sim. treat.) and post-treatment
(Post-treat.). Values of anti-cytotoxicity effect at the concentration of 50
μg.mL-1 were used to perform Pearson correlation analysis. Values of
anti-cytotoxicity effect at the concentration of 50 μg.mL-1 were used to
perform PCA analysis. In Pearson correlation analysis (Table 8), values
followed by positive sign suggest a directly proportional relation between the
factors. Thus, the positive correlation between phenol and flavonoid total
content and FRAP and Fe2+ chelating assays suggest the increasing of
antioxidant activity, as well as, the positive correlation between phenol and
flavonoid and AGS cytotoxicity suggest the increasing of the anticancer effect.
In addition, FRAP and Fe2+ chelating antioxidants are strongly
correlated to the anticancer effects against AGS cells. Anti-cytotoxicity
protocols were used to evaluate the ability of extracts inhibit or prevent
cytotoxic damage induced by cisplatin. Similarly, considering positive
correlations between the total tannin content and pre and simultaneous
treatment tests suggest that an increase in tannins availability interferes
positively with cell viability of human lymphocytes, as well as, tannins
content interfere with human lymphocytes cell viability. Table 8: Pearson correlation analysis
between total phenols, flavonoids and tannins content analysed in V. polyanthes
and G. parviflora extracts and their antioxidant activities in FRAP and Fe2+
chelating activity and cytotoxic, anti-cytotoxic and anticancer effects by MTT
assay.
Cell viability was evaluated by MTT assay
using: human lymphocytes (HL MTT), S-180 (S-180 MTT) and AGS cells (AGS MTT);
or after perform the protocols of pre (Pre-treat.), simultaneous (Sim. treat.)
and post-treatment (Post-treat.). Values of anti-cytotoxicity effect at the
concentration of 50 μg.mL-1 were used to perform Pearson correlation
analysis. Marzouk and Abd Elhalim [72],
using NMR technique, found in the extract of V. leopoldii aerial parts compounds previously not reported in the
literature, characterized as sesquiterpene lactones, triterpene tetracyclic and
apigenin-7-O-glucide and luteolin-7-O-glucide. According to the authors,
chemical and pharmacological investigations have shown that the sesquiterpene
lactones found in plants of the genus Vernonia
present antitumor activities, and some sesquiterpene lactones may exhibit
strong cytotoxicity against tumor cell lines. Sesquiterpene lactones identified in V. polyanthes by the APCI (+) FT-ICR MS
technique (8β-2
methylacryloyloxy-isohirsutinolide, piptocarpine A and 10α-acetoxy-8α-methylacryloyloxy-1
α-13-O-acetate or 1β-methoxyhirsut -O-acetate) may have contributed to the
antiproliferative effects on S-180 and gastric adenocarcinoma cells. Considering
that sesquiterpene lactones are chemical markers of the Asteraceae family and
of the genus Vernonia, it was
expected to find compounds of this chemical class in the extracts of the herbs
investigated in our study. In the review of Ghantous et al. [73],
sesquiterpene lactones are led clinical trials of cancer, as well as, the
authors relate the good performance of these substances in cancer clinical trials
to the structure-activity of sesquiterpene lactones (lipophilicity and geometry). Similar to studies with V. polyanthes, to our knowledge, there are not studies in the
literature that relate G. parviflora
extracts to the cytotoxicity in human lymphocyte cells, S-180 and AGS. The
study of Bazylko et al. [57] evaluated the potential
cytotoxicity of aqueous and ethanolic extracts of G. parviflora and its protective effect against damage caused by UV
(ultraviolet) irradiation in human skin fibroblast cells. The authors concluded
that the ethanolic extract was cytotoxic, presenting intense effect on the
generation of reactive species in fibroblasts after UVB irradiation exposure. On
the contrary, the aqueous extract exhibited protective activity in fibroblasts,
preventing the decrease in proliferative activity and the increase in apoptosis
caused by UVA and UVB irradiation, by the inhibition of EROS generation. Parzonko and Kiss [59] investigated the photo-protective effects of two derivatives of caffeic
acid isolated from aerial parts of G.
parviflora (2,3,5- or 2,4,5-tricafeoilaltrarico acid (TCA) and 2,4- or 3,5
-dicafoilglicaric acid (DCG)), in human dermal fibroblasts. In conclusion, the
study clearly demonstrated that the derivatives of caffeic acid found in G. parviflora, in particular TCA, protect
cells against damage caused by UVA radiation. 4. CONCLUSIONS AND RECOMMENDATIONS
Despite
belonging to the same family, our analyses suggest that the studied plants present
different content of phenols, flavonoids and tannins. It was identified Poly
Unsaturated Fatty Acids (PUFA) in G. parviflora extract, being the first record of such
compound for this plant species. Regarding anticancer effects, both species
were able to reduce S-180 cell viability, and V. polyanthes extract showed high antiproliferative potential
against AGS cells. In the anti-cytotoxic assay, V. polyanthes was more efficient in
repairing cytotoxic cisplatin-induced damage. Chemical content of G.
parviflora and V. polyanthes seems interfere with antioxidant and cytotoxic effects exhibited
for the extracts. There are several drugs for the treatment of cancer. In
this scenario, our results reinforce the use of G. parviflora and V.
polyanthes for medicinal and nutraceutical purposes, as well
as suggest their potential use for the development of new drugs for the treatment
of cancer. However, further investigations are needed to verify the
biological activities of these plants. SOURCES OF FUNDINGThis research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors. CONFLICT OF INTERESTThe author have declared that no competing interests exist. ACKNOWLEDGMENTNone. REFERENCES
[4]
Lorenzi
H, Matos FJ. Plantas medicinais no Brasil: nativas e exóticas. 2002.
This work is licensed under a: Creative Commons Attribution 4.0 International License © Granthaalayah 2014-2020. All Rights Reserved. |